Veterinary Research Communications

, Volume 35, Issue 2, pp 103–121 | Cite as

Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells

  • Arianna Barbara Lovati
  • Bruna Corradetti
  • Anna Lange Consiglio
  • Camilla Recordati
  • Elisa Bonacina
  • Davide Bizzaro
  • Fausto Cremonesi
Original Article


The aim of the study was to compare in vitro the stemness features of horse progenitor cells derived from bone marrow (BM-MSCs), amniotic fluid (AF-MSCs) and umbilical cord matrix (EUC-MSCs). It has been suggested that there may be a stem cell population within both umbilical cord matrix and amniotic fluid. However, little knowledge exists about the characteristics of these progenitor cells within these sources in the equine species. This study wanted to investigate an alternative and non-invasive stem cell source for the equine tissue engineering and to learn more about the properties of these cells for future cell banking. Bone marrow, umbilical cord and amniotic fluid samples were harvested from different horses. Cells were analyzed for proliferation, immunocytochemical, stem cell gene expression and multilineage plasticity. BM- and AF-MSCs took similar time to reach confluence and showed comparable plating efficiency. All cell lines expressed identical stem cell markers and capability to differentiate towards osteogenic lineage. Almost all cell lines differentiated into the adipogenic lineage as demonstrated by cytochemical staining, even if no adipose gene expression was detectable for AF-MSCs. AF- and EUC-MSCs showed a limited chondrogenic differentiation compared with BM-MSCs as demonstrated by histological and biochemical analyses. These findings suggest that AF-MSCs appeared to be a readily obtainable and highly proliferative cell line from an uninvasive source that may represent a good model system for stem cell biology. More studies are needed to investigate their multilineage potential. EUC-MSCs need to be further investigated regarding their particular behavior in vitro represented by spheroid formation.


Progenitor cells Equine Bone marrow Umbilical cord matrix Amniotic fluid Characterization 

Supplementary material

11259_2010_9457_MOESM1_ESM.tif (5.9 mb)
Fig. 4Immunostaining characterization of BM-, AF and EUC-MSCs. Cells were stained just with the secondary antibodies to evaluate their negative response (Magnification: 20X; scale bars: 20 μm) (TIFF 6008 kb)


  1. Armesilla-Diaz A, Elvira G, Silva A (2009) p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells. Exp Cell Res 315:3598–3610PubMedCrossRefGoogle Scholar
  2. Barbero A, Ploegert S, Heberer M et al (2003) Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 48:1315–1325PubMedCrossRefGoogle Scholar
  3. Barholomew S, Owens SD, Ferraro GL, Carrade DD et al (2009) Collection of equine cord blood and placental tissues in 40 Thoroughbred mares. Equine Vet J 41(8):724–728CrossRefGoogle Scholar
  4. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I et al (2007) Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differ Res Biol Divers 75:279–291Google Scholar
  5. Carlin R, Davis D, Weiss M, Schultz B, Troyer D (2006) Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 4:8PubMedCrossRefGoogle Scholar
  6. Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, Hwang SM (2006) Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24:679–685PubMedCrossRefGoogle Scholar
  7. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, Harris IR, Popma SH, Sachs DH, Huang CA (2008) Immunogenicity of umbilical cord tissue derived cells. Blood 111:430–438PubMedCrossRefGoogle Scholar
  8. Cremonesi F, et al. (2008) Isolation in vitro culture and characterization of foal umbilical cord cells at birth. Vet Res Comm. doi:10.1007/s11259
  9. Da Sacco S, Sedrakyan S, Boldrin F, Giuliani S, Parnigotto PP et al (2010) Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 183:1193–1200PubMedCrossRefGoogle Scholar
  10. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serrem A, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100–106PubMedCrossRefGoogle Scholar
  11. De la Fuente R, Abad JL, Garcia-Castro J et al (2004) Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. Exp Cell Res 297:313–328PubMedCrossRefGoogle Scholar
  12. Delo DM, De Coppi P, Bartsch G Jr, Atala A (2006) Amniotic fluid and placental stem cells. Meth Enzymol 419:426–438PubMedCrossRefGoogle Scholar
  13. Fehrer C, Lepperdinger G (2005) Mesenchymal stem cell aging. Exp Gerontol 40:926–930PubMedCrossRefGoogle Scholar
  14. Fortier LA, Smith RK (2008) Regenerative medicine for tendinous and ligamentous injuries of sport horses. Vet Clin North Am Equine Pract 24(1):191–201PubMedCrossRefGoogle Scholar
  15. Gucciardo L, Lories R, Ochsenbein-Kolble N, Done’ E, Zwijsen A, Deprest J (2009) Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG 116:166–172PubMedCrossRefGoogle Scholar
  16. Guest DJ, Smith MR, Allen WR (2008) Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Equine Vet J 40(2):178–181PubMedCrossRefGoogle Scholar
  17. Hipp J, Atala A (2008) Sources of stem cells for regenerative medicine. Stem Cell Rev 4:3–11PubMedCrossRefGoogle Scholar
  18. Hoynowski SM, Fry MM, Gardner BM, Leming MT, Tucker JR, Black L et al (2007) Characterization and differentiation of equine umbilical cord-derived matrix cells. Biochem Biophys Res Commun 362:347–353PubMedCrossRefGoogle Scholar
  19. In’t Anker PS, Scherjon SA, Kleijburg van der Keur C, Noort WA, Claas FH, Willemze R et al (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548–1549CrossRefGoogle Scholar
  20. Ishige I, Nagamura-Inoue T et al (2009) Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord. Int J Hematol 90:261–269PubMedCrossRefGoogle Scholar
  21. Jomura S, Uy M, Mitchell K, Dallasen R et al (2007) Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells. Stem Cells 25:98–106PubMedCrossRefGoogle Scholar
  22. Kaviani A, Perry TE, Dzakovic A et al (2001) The AF as a source of cells for fetal tissue engineering. J Pediatr Surg 36:1662–1665PubMedCrossRefGoogle Scholar
  23. Koch T, Heerkens T, Thomsen PD, Betts DH (2007) Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 7:26PubMedCrossRefGoogle Scholar
  24. Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204–213PubMedCrossRefGoogle Scholar
  25. Marcus AJ, Woodbury D (2008) Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med 12:730–742PubMedCrossRefGoogle Scholar
  26. Miki T, Strom SC (2006) Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev 2:133–141PubMedCrossRefGoogle Scholar
  27. Mueller SM, Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagensponges. J Cell Biochem 82:583–590PubMedCrossRefGoogle Scholar
  28. Nanaev AK, Kohnen G, Milovanov AP, Domogatsky SP, Kaufmann P (1997) Stromal differentiation and architecture of the human umbilical cord. Placenta 18:53–64PubMedCrossRefGoogle Scholar
  29. Pacini S, Spinabella S, Trombi L et al (2007) Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in racehorses. Tissue Eng 13(12):2949–2955PubMedCrossRefGoogle Scholar
  30. Pan GJ, Chang ZY, Scholer HR, Pei D (2002) Stem cell pluripotency and transcription factor Oct4. Cell Res 12:321–329PubMedCrossRefGoogle Scholar
  31. Park SB, Seo MS, Kang JG, Chae JS, Kang KS (2010) Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. Cytotherapy. doi:10.3109/14653249.2010.520312
  32. Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M et al (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cell 26:300–311CrossRefGoogle Scholar
  33. Passeri S, Nocchi F, Lamanna R, Lapi S et al (2009) Isolation and expansion of equine umbilical cord-derived matrix cells (EUCMCs). Cell Biol Int 33:100–105PubMedCrossRefGoogle Scholar
  34. Petsa A, Gargani S, Felesakis A, Grigoriadis N, Grigoriadis I (2009) Effectiveness of protocol for the isolation of Wharton’s Jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim 45:573–576CrossRefGoogle Scholar
  35. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147PubMedCrossRefGoogle Scholar
  36. Pochampally RR, Smith JR, Ylostalo J, Prockop DJ (2004) Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103(5):1647–1652PubMedCrossRefGoogle Scholar
  37. Prusa AR, Hengstschlager M (2002) Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit 8:RA253–RA257PubMedGoogle Scholar
  38. Reed SA, Johnson SE (2008) Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol 215:329–336PubMedCrossRefGoogle Scholar
  39. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S et al (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324–336PubMedCrossRefGoogle Scholar
  40. Sarugaser R, Ennis J, Stanford WL, Davies JE (2009) Isolation, propagation, and characterization of human umbilical cord perivascular cells (EUCPVCs). Methods Mol Biol 482:269–279PubMedCrossRefGoogle Scholar
  41. Secco M, Zucconi E, Vieira NM et al (2008) Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 26:146–150PubMedCrossRefGoogle Scholar
  42. Sessarego N, Parodi A, Podestà M, Benvenuto F, Mogni M et al (2008) Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 93(3):339–346PubMedCrossRefGoogle Scholar
  43. Smith RK, Korda M, Blunn GW (2003) Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 35(1):99–102PubMedCrossRefGoogle Scholar
  44. Troyer DL, Weiss ML (2008) Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591–599PubMedCrossRefGoogle Scholar
  45. Wang M, Yoshida A, Kawashima H et al (2006) Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber. Invest Ophthalmol Vis Sci 47:1522–1532PubMedCrossRefGoogle Scholar
  46. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR (2008) Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells 26:2865–2874PubMedCrossRefGoogle Scholar
  47. Wilke MM, Nydam DV, Nixon AJ (2007) Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 25(7):913–925PubMedCrossRefGoogle Scholar
  48. You Q, Cai L, Zheng J, Tong X et al (2008) Isolation of human mesenchymal stem cells from third-trimester amniotic fluid. Int J Gynecol Obstet 103:149–152CrossRefGoogle Scholar
  49. Zangrossi S, Marabese M, Broggini M, Giordano R et al (2007) Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25(7):1675–1680PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Arianna Barbara Lovati
    • 1
  • Bruna Corradetti
    • 2
  • Anna Lange Consiglio
    • 1
  • Camilla Recordati
    • 4
  • Elisa Bonacina
    • 3
  • Davide Bizzaro
    • 2
  • Fausto Cremonesi
    • 1
  1. 1.Department of Veterinary Clinical Science, Equine Reproduction UnitUniversità degli Studi di MilanoLodiItaly
  2. 2.Department of Biochemistry, Biology and GeneticsUniversità Politecnica delle MarcheAnconaItaly
  3. 3.IRCCS Istituto Ortopedico GaleazziCell and Tissue Engineering LaboratoryMilanItaly
  4. 4.Mouse & Animal Pathology Laboratory (MAPLab)—FONDAZIONE FILARETE Viale Ortles 22/4Milano (MI)Italy

Personalised recommendations